Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?
- PMID: 23512465
- DOI: 10.1007/s10096-013-1858-0
Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?
Abstract
Otitis media is the second most common infection in children and the leading cause for seeking medical advice. Indigenous populations such as the Inuits, indigenous Australians and American Indians have a very high prevalence of otitis media and are considered to be high-risk populations. Streptococcus pneumoniae, one of the three main bacterial causes of otitis media, colonises the nasopharynx prior to disease development. In high-risk populations, early acquisition of high bacterial loads increases the prevalence of otitis media. In these settings, current treatment strategies are insufficient. Vaccination is effective against invasive pneumococcal infection but has a limited impact on otitis media. Decreasing the bacterial loads of otitis media pathogens and/or colonising the nasopharynx with beneficial bacteria may reduce the prevalence of otitis media. Probiotics are live microorganisms that offer health benefits by modulating the microbial community and enhancing host immunity. The available data suggest that probiotics may be beneficial in otitis media. This review discusses the potential use of probiotics to reduce pathogen colonisation and decrease the prevalence of otitis media, providing justification for further investigation.
Similar articles
-
Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.PLoS One. 2017 Feb 1;12(2):e0170316. doi: 10.1371/journal.pone.0170316. eCollection 2017. PLoS One. 2017. PMID: 28146590 Free PMC article.
-
The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media.J Microbiol Immunol Infect. 2017 Oct;50(5):714-717. doi: 10.1016/j.jmii.2015.08.009. Epub 2015 Sep 9. J Microbiol Immunol Infect. 2017. PMID: 26507672
-
Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.Clin Nutr. 2007 Jun;26(3):314-21. doi: 10.1016/j.clnu.2007.01.003. Epub 2007 Mar 13. Clin Nutr. 2007. PMID: 17353072 Clinical Trial.
-
The prevention of pneumococcal disease in children.N Engl J Med. 2001 Oct 18;345(16):1177-83. doi: 10.1056/NEJMra010462. N Engl J Med. 2001. PMID: 11642234 Review. No abstract available.
-
Pneumococcal conjugate vaccine for young children.Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Manag Care. 2000. PMID: 11116663 Review.
Cited by
-
Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections.Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2075-80. doi: 10.1007/s10096-015-2454-2. Epub 2015 Jul 24. Eur J Clin Microbiol Infect Dis. 2015. PMID: 26205666
-
Complementary and Alternative Medicine Treatment Options for Otitis Media: A Systematic Review.Medicine (Baltimore). 2016 Feb;95(6):e2695. doi: 10.1097/MD.0000000000002695. Medicine (Baltimore). 2016. PMID: 26871802 Free PMC article. Review.
-
Reflections on pneumonia in the tropics.Pneumonia (Nathan). 2014 Dec 1;4:1-7. doi: 10.15172/pneu.2014.4/416. eCollection 2014. Pneumonia (Nathan). 2014. PMID: 31641567 Free PMC article. Review.
-
The respiratory microbiota during health and disease: a paediatric perspective.Pneumonia (Nathan). 2015 Dec 1;6:90-100. doi: 10.15172/pneu.2015.6/656. eCollection 2015. Pneumonia (Nathan). 2015. PMID: 31641583 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical